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Epstein-Barr virus (EBV) is a highly efficient acute transforming agent in human cells, provided that the
intact virus is used. To investigate the ability of viral DNA alone to transform cells, we introduced the EBV
genome into human lymphocytes. After microinjection of EBV DNA into neonatal B lymphocytes, we
established a cell line that in early passages contained multiple viral fragments. This cell line retained sequences
from the short, unique (U,) region of the EBV genome and sequences from EcoRI-E. The viral sequences were
not expressed; however, the cells expressed a 2.3-kilobase polyadenylated message homologous to the c-fgr
oncogene, a cellular locus believed to be activated by EBV infection [M. S. C. Cheah, T. J. Ley, S. R. Tronick,
and K. C. Robbins, Nature (London) 319:238-240.]. The cell line was monoclonal with rearrangement at the
immunoglobulin locus and had a reciprocal translocation t(1;7)(p34;q34) and a deletion of sequences within the
locus for the beta chain of the T-cell receptor. The close proximity of the translocation to the chromosomal loci
for c-fgr on chromosome 1 and the T-cell receptor beta chain on chromosome 7 suggests that structural
alteration of these genes was critical to this transformation event.
Although infection of B lymphocytes with Epstein-Barr
virus (EBV) routinely results in transformation (37), identi-
fication of transforming functions of EBV by gene transfer
has been an elusive objective. One impediment has been the
difficulty in delivering viral DNA into these cells. Lympho-
cytes are nuclease rich and relatively refractory to transfec-
tion. Microinjection has been used to introduce EBV DNA
into human and rat fibroblasts and African green monkey
kidney cells (13); early antigen expression was induced in the
recipient cells. EBV DNA has been successfully transfected
into human placental, Vero, BSC-1, and owl monkey kidney
cells (15). These cells did not express EBV nuclear antigen
but did express antigens associated with a productive viral
cycle. However, synthesis of EBNA has been induced in
lymphocytes after Sendai virus envelope-mediated gene
transfer of the entire EBV genome or cloned fragments of
EBV DNA (49). These studies indicated that induction of
EBNA and transient growth stimulation could be induced in
lymphoid cells, but the recipient cells were not permanently
transformed. This inability to transform perhaps occurred
because the viral DNA was damaged during transfer through
the cytoplasm and was not stably maintained.
Studies of the sensitivity of transformation to inactivation
(17, 30) and of viral transcription in latently infected growth-
transformed cells (26) have indicated that the transformation
process is complex and involves much of the genome. To
determine whether EBV-induced growth transformation of
lymphocytes could occur in the absence of infection by
whole virus, we microinjected EBV (B95-8) DNA purified
from virions into the nuclei of mononuclear cells obtained
from human umbilical cord blood. Injection ofDNA directly
into nuclei may prevent DNA degradation which may occur
in the cytoplasm after transfection, electroporation, or ves-
icle fusion. Neonatal lymphocytes are ideal for such studies
as they do not spontaneously transform, nor do they exhibit
chromosomal abnormalities in culture. In contrast to the
uninjected cord lymphocytes, injection of cells with B95-8
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viral DNA consistently resulted in transient growth stimula-
tion for several months in culture. Only one of these abortive
transformations resulted in establishment of a permanent
cell line. This paper describes an analysis of the EBV DNA
content of this cell line and the chromosomal abnormalities
which may have contributed to the transformation event.
MATERIALS AND METHODS
Isolation of B lymphocytes. Mononuclear leukocytes were
obtained by centrifugation of fresh human cord blood on
Ficoll (LSM; Litton Bionetics). The leukocyte layer was
depleted of monocytes by incubation in plastic tissue culture
ware which had been pretreated with fetal calf serum.
Nonadherent cells were washed and suspended in
RPMI-20% fetal calf serum until use. Just before microin-
jection, monolayers were prepared with anti-human F(ab')2-
treated polystyrene petri dishes. Petri dishes were incubated
for 30 min at 37°C with affinity-purified goat anti-human
F(ab')2 (Atlantic Antibodies). The monocyte-depleted cord
blood lymphocytes were allowed to adhere to the F(ab')2
antibody for 30 min at 37°C. Nonadherent T cells were
washed from the petri dishes, providing a B-cell-enriched
monolayer target for microinjection.
Preparation of EBV DNA. EBV was obtained from the
supernatant fluids of 12-O-tetradecanoylphorbol acetate-
induced B95-8 cells by centrifugation and layered onto a 15
to 30% sucrose gradient. Virions thus obtained were treated
with proteinase K and sodium dodecyl sulfate. Viral DNA
was isolated by CsCl density gradient centrifugation. After
ethanol precipitation, the viral DNA was suspended in
microinjection buffer (114 mM KCI, 20 mM NaCl, 3 mM
NaH2PO4- H20, 3 mM MgCl2 - 6H20, pH 7.4).
Microinjection. Recipient cells were microinjected with
glass microcapillaries drawn with a de Fonbrune microforge
(Curtin Matheson Scientific, Inc.). Injections were carried
out on a Zeiss IM inverted phase-contrast microscope.
Micromanipulators provided control of the microcapillary
needle, and a Hamilton syringe allowed maintenance of
continuous pressure on the DNA solution. Microinjection
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FIG. 1. Linkage map of BamHI and EcoRI restriction endonuclease fragments of the EBV genome. Below is a schematic map of the
arrangement of unique (U) and internal repeat (IR) sequences of virion DNA and of the terminal repeats (TR), which vary in number, at each
end of the molecule. d, Dalton.
was controlled by determining visually by cellular refractile
changes that solution had been delivered. Approximately
200 cells were injected per assay. DNA concentration was
adjusted to deliver five copies of EBV DNA per 10-fl
injection.
Nucleic acid preparation and hybridization conditions. For
isolation of nucleic acids for hybridization, cells were lysed
in 4 M guanidine isothiocyanate-0.5% sarcosyl solution, and
the lysate was centrifuged in a CsCl step gradient. Poly(A)+
RNA was obtained by oligo(dT)-cellulose chromatography.
The DNA was dialyzed against 10 mM Tris hydrochloride-1
mM EDTA, pH 8.0, ethanol precipitated, and digested with
EcoRI. After electrophoresis and transfer to nitrocellulose,
the DNA was probed with BamHI or EcoRI fragments of
EBV DNA. These isolation procedures were carried out at
periodic intervals after cell outgrowth.
Hybridization with 32P-labeled recombinant EBV DNA
probes was done in buffer consisting of lOx Denhardt
reagent, 100 ,ug of single-stranded calf thymus DNA per ml,
100 ,ug of poly(A) per ml, 0.2% sodium dodecyl sulfate, and
6x SSC (lx SSC is 0.15 M NaCl plus 0.015 M sodium
citrate). The labeled probe was hybridized to pretreated
blots at 72°C for 18 h. The blots were washed at 72°C in 0.2%
sodium dodecyl sulfate in decreasing SSC concentration to
0.1x SSC. Hybridizations to pHJ and T-beta probes (see
below) were done at 68°C in buffer as stated above; the blots
were washed at 68°C.
The EBV BamHI C fragment was cloned into the pGEM-2
vector to allow generation of SP6 transcripts for Southern
and Northern blot hybridizations. SP6 BamHI-C labeled
with 32p was hybridized in buffer containing 50% formamide
at 50°C. Washes were done at 75°C in the aqueous buffer
described above.
A 0.841-kilobase AvaI-BamHI fragment of v-fgr which
contains only the tyrosine kinase sequences of the oncogene
was subcloned into the pGEM1 vector. Transcripts from 2
jig of linearized DNA template were labeled with [32P]GTP
in a 50-,ul reaction mixture consisting of 40 mM Tris hydro-
chloride (pH 7.5), 6 mM MgCl2, 2 mM spermidine, 100 ,ug of
bovine serum albumin per ml, 10 mM dithiothreitol, and 20
U of SP6 polymerase with a 0.5 mM concentration of each
unlabeled nucleotide. Northern blots were hybridized in 50%
formamide at 44°C for 18 h. The blots were washed at 65°C
in 0.2% sodium dodecyl sulfate-0.1% sodium pyrophosphate
in SSC in decreasing concentrations to 0.1x SSC. RNase
digestion at 37°C was included in the wash protocol.
Probes. Cloned BamHI and EcoRI EBV (W91) fragments
were used to detect EBV DNA in EcoRI-digested DNA from
the microinjected cells (39). BamHI-C, subcloned into the
pGEM-2 vector, was used in later hybridizations to both
Southern and Northern blots of poly(A)+ RNA. pHJ (10), a
probe specific for the joining region of the human immuno-
globulin heavy chain, was used to probe HindIII-digested
cellular DNAs. A cDNA clone, Jurkat-2 (52), specific for the
beta chain of the T-cell receptor was used to probe EcoRI-
digested cellular DNAs. A 0.841-kb AvaI-BamHI fragment
of v-fgr ligated into pGEM-1 was used to probe Northern
blots of poly(A)+ RNA from the microinjected cell line.
RESULTS
Establishment of the MIB cell line. Transformation of cord
blood lymphocytes by microinjection of EBV DNA was a
rare event. In 23 attempts to transform cells with B95-8
DNA, only one permanent line was established. Microin-
jected and uninjected cells from the same cord blood prep-
aration were allowed to elute from (Fab')2-treated petri
dishes, and these cells were cultured together. The majority
of cultures could not be expanded, and the cells died within
2 months. In six of the assays, cells remained viable for 3 to
5 months; in that time, culture volumes were expanded as
cell numbers increased. The usual circumstance was even-
tual decline in cell numbers and death of the culture. Only in
the case of MIB could expansion of the cell culture continue
as a permanent line was established.
EBV DNA content. EBV DNA within the virion is a
172-kb-pair linear genome containing multiple random nicks
(38). Although the standard EBV-transformed lymphoblas-
toid cell lines contain the intact EBV genome, usually
episomal (1, 16, 32, 34), some fragmentation of the genome
could occur during viral DNA isolation or during the
microinjection process itself. It was therefore anticipated
that not all viral sequences would necessarily be retained in
this transformed cell line. To identify the viral sequences
retained, high-molecular-weight DNA was extracted from
the MIB cell line, digested with EcoRI, transferred to
nitrocellulose, and hybridized to 32P-labeled EcoRI or
BamHI EBV (W91) recombinant fragments (Fig. 1). DNA
preparations from the early outgrowth of MIB contained
fragments homologous to the EBV fragments listed in Table
1. The majority of these fragments were not detectable in
preparations of DNA from later passages. Loss of viral
sequences during passage could be due to unstable integra-
tive events in contrast to the regulated replication and
expression of the intact EBV plasmid.
Table 1 shows the hybridization results obtained with
duplicate Southern blots of EcoRI-digested cellular DNA. In
intact viral DNA, EcoRI-A is a 30- to 45-kb fragment,
depending on the number of IR1 sequences it includes.
However, hybridization with EcoRI-A to the EcoRI-digested
MIB DNA identified four fragments with molecular weights
of 16.5, 6.6, 4.2, and 2.0 kb. The 6.6- and 4.2-kb fragments
were also detected with BamHI-C, and the 2.0-kb fragment
was detected by BamHI-V; both sequences map within
EcoRI-A. The multiple EcoRI fragments indicate that the
entire EcoRI-A sequence was not retained and that small
I -1
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fragments of this sequence integrated into cell DNA. Multi-
ple EcoRI fragments were also detected with EcoRI-E (5.2,
4.5, and 2.8 kb) and EcoRI-Dhet (6.6, 3.8, and 3.2 kb). In the
intact genome, EcoRI-E is 11.3 kb in size, EcoRI-Dhet
varies with a range of 11.1 to 13.8 kb. The sequences
detected in MIB represent portions of these EcoRI frag-
ments. In the hybridizations to DNA derived from early cell
passages, only EcoRI-F detected a fragment of the expected
size, 8.1 kb. Hybridization with the EcoRI-B sequence
detects 18-, 10.5-, and 3.6-kb fragments in the cellular DNA.
BamHI-B, which maps within the EcoRI-B sequence, hy-
bridized to 18-, 12.3-, 6.9-, and 3.6-kb fragments in MIB
DNA. These data indicated that, at early times after cell
outgrowth, not all viral sequences were retained. The mul-
tiple EcoRI fragments detected by several of the probes
indicated that multiple rearrangements or integrative events
occurred. Further analysis of the DNA from the transformed
line was carried out at later passages to determine whether
the loss of viral sequences was a continuing process.
Hybridization to DNA from later passages was compared
with hybridizations to reconstructions of 1, 10, or 100 copies
of the recombinant fragment or dilutions of cellular DNA
from the latently infected Raji cell line which contains
approximately 60 copies of the EBV genome. Hybridization
with BamHI-V, -X, -H, and -F within EcoRI-A, BamHI-K
within EcoRI-B, BamHI-E, or EcoRI fragments DIJhet, F,
and Gl, which detected one copy in reconstruction hybrid-
izations, detected no homologous fragments in MIB DNA.
TABLE 1. Sequences detected by hybridization with
recombinant EBV nick-translated probes or SP6-generated
riboprobes against Southern blots of DNA extracted from
transformed MIB cells 4 months or 1 year after
the start of cell outgrowtha
EcoRI restriction fragment(s) (kb) detected after:
Probe
























a Cellular DNA was digested with EcoRI.
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FIG. 2. Hybridization with SP6 BamHI-C, a riboprobe specific
for the BamHI-C region of EBV. BamHI-C was cloned into the
pGEM-2 vector, and RNA was synthesized with SP6 polymerase; 2
x 108 cpm of labeled RNA was hybridized to Southern blots of
EcoRI-digested DNA from the microinjected cell line (MI), H9 (a
T-cell leukemia), Bjab (an EBV-negative BL line), and Raji (an
EBV-positive BL line). Raji DNA was diluted 1/50. Hybridization
was carried out in 50% formamide at 55°C. Blots were washed at
75°C, and a ribonuclease A treatment at 370C was included in the
wash protocol. A 3.0-kb band was visible in the MIB line (lane 1)
and in Raji DNA (lane 4) after hybridization with SP6 BamHI-C
RNA. This represents the EcoRI J fragment of EBV, which maps
within the BamHI C fragment. Also present in lane 4 is a 3.9-kb band
representing EcoRI-I sequences in Raji DNA. The probe did not
detect sequences in either Bjab or H9 DNA.
Hybridizations with BamHI-B, -Y, and -R within EcoRI-B,
EcoRI-C, and EcoRI-H detected 7.5-kb fragments. An iden-
tically sized fragment was detected with a clone representing
ribosomal DNA. Homology of EBV and herpes simplex
virus DNAs with ribosomal sequences has been previously
described (24, 51). Hybridization with EcoRI-E faintly de-
tected a 2.8-kb fragment within the MIB cell line but did not
detect sequences in DNA prepared from the EBV-negative
H9 or Bjab cell line. In early passages, hybridization with the
EcoRI E fragment had also detected a 2.8-kb fragment in
MIB DNA. Hybridization with a 32P-labeled SP6 riboprobe
of BamHI-C, synthesized from right to left on the EBV
genome, detected an intact EcoRI J fragment in the MIB cell
line and in a 1:50 dilution of Raji DNA (Fig. 2). Although the
EBV copy number in Raji may vary from 50 to 100 copies,
the lower intensity of hybridization in the MIB cell line may
indicate that viral DNA is present at less than one copy per
cell. To summarize, the only viral DNA sequences that were
retained in later cell passages of the MIB cell line included an
intact EcoRI J fragment and a small sequence from EcoRI-E.
We cannot exclude the possibility that additional frag-
J. VIROL.
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FIG. 3. (A) Cellular DNAs digested with HindIll and probed with pHJ, a probe specific for the joining region of the human
immunoglobulin heavy chain. The pHJ probe was labeled by nick translation with [a-32P]dCTP and hybridized to Southern blots of cellular
DNA digested with HindIII. Germ line configuration is present in a T-cell leukemia line, H9 (lane3), and in nasopharyngeal carcinoma (NPC)
tissue (lane 5). The germ line band is 10.2 kb. An identical rearranged band at 8.7 kb is visible in the MIB line (lane 1) and in DNA of Bjab,
an EBV-negative B-lymphoblastoid line (lane 4). The B-cell leukemic DNA has rearranged bands at 5.7 and 3.9 kb (lane 2). The intensity of
hybridization in lane 2 is due to unequal loading of DNA. (B) EcoRI-digested cellular DNA probed with the cDNA clone Jurkat-2, which is
specific for the beta chain of the T-cell receptor. The T-beta probe, isolated as insert DNA, was labeled by nick translation and hybridized
to Southern blots of cellular DNAs. Lanes 3 to 5, containing DNAs from an NPC biopsy, Bjab, and Raji, respectively, represent the germ
line configuration of T-beta sequences. The two constant (C) regions (C,1 and C,2) and the variable (V)- region genes are labeled at the right.
H9, a T-cell leukemic line (lane 2), and MIB (lane 1) exhibit rearranged C131 bands at 9.0, 16.0, and 27.0 kb. Arrows at the left mark these
rearranged fragments.
ments ofEBV DNA have been retained in MIB cells. Probes
which detect homologous sequences in one-copy reconstruc-
tions may not have detected those sequences in MIB. The
EcoRI-E sequences appeared to be present at much less than
one copy per cell; this retention at low level may be true of
other EBV sequences as well.
Lack of transcription from retained sequences. At later cell
passages, when it had been determined that sequences from
EcoRI-J and -E were still retained, possible transcription
from these sequences was investigated. The EcoRI-J se-
quence within BamHI-C hybridizes to a number of early and
late EBV mRNAs (20, 21). A 2.3-kb mRNA and a 2.0-kb
mRNA are known to be partly transcribed from this region in
latently infected cells. Throughout EBV infection, two small
poly(A)- transcripts (the EBV-encoded RNAs [EBERS])
are present in abundance. The coding sequences for the
EBERS are wholly within the EcoRI J fragment of EBV (4,
43). To determine whether the EcoRI-J sequences were
expressed in the MIB cells, Northern blots were prepared
from poly(A)- and poly(A)+ RNAs. These were probed with
a BamHI-C SP6 transcript. There was no evidence of
expression of EcoRI-J in the MIB cell line although the
probe detected abundant transcription from the EcoRI-J
sequence in B95-8 cells; transcription of the 4.75-kb late
transcript and the EBERS was seen with this probe in these
productively infected cells.
Although fragments of 5.2, 4.5, and 2.8 kb homologous to
EcoRI-E were found in early passages of MIB, only the
2.8-kb sequence was retained in late passages of the line and
was present at less than one copy per cell. A nick-translated
EcoRI-E probe detected no transcription from the region
when Northern blots of poly(A)+ RNA from MIB were
probed. Griffin and Karran (14) obtained immortalized Afri-
can green monkey kidney cell lines after transfection with
cosmid clones containing EcoRI-E sequences. The retention
of EcoRI-E sequences in transformation events in both
epithelial cells and lymphocytes is interesting.
Determination of clonality of the cell line. The detection of
multiple fragments of EcoRI-digested MIB DNA homolo-
gous to BamHI-C, BamHI-V, EcoRI-E, EcoRI-Dhet, and
EcoRI-B suggested that the cell line was polyclonal and that
the hybridization data reflected different integration events
within several microinjected cells. The clonality of cells of
lymphocytic origin can be assessed by determining the
pattern of rearrangement of immunoglobulin or T-cell recep-
tor genes (2, 3, 50).
To assess the clonality of the MIB cell line, immunoglob-
ulin gene rearrangement was analyzed by using the pHJ
probe which contains the joining-region sequences of the
immunoglobulin heavy-chain locus (10). MIB DNA was
compared with DNAs fromn. a-well.differentiated EBV-
positive B-cell leukemia, Leu, and Bjab, an immunoglobulin-
producing EBV-negative B-cell line (Fig. 3A). The unrear-
ranged genomic fragment of 10.2 kb was detected in
nasopharyngeal carcinoma and T-cell lymphoma (H9)
DNAs. HindIll digestion revealed clear rearrangement in
the leukemia DNA with bands of 5.7 and 3.9 kb and
rearrangement in the MIB cell line with an additional band at
8.7 kb. A band of similar size was detected in the Bjab cell
line. Restriction with EcoRI and BamHI also identified
similar gene rearrangement in the Bjab and MIB cell lines
(data not shown) although the two cell lines have clearly
.4 5.7
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distinct karyotype and surface markers (27). The pattern of
rearrangement of MIB DNA at the immunoglobulin-joining
region suggests that these cells are a clonal population of
B-cell lineage. Rearrangement at this locus occurs early in
B-cell development and is not seen in T-cell neoplasia (35).
Karyotype analysis provided additional evidence for the
monoclonal nature of the MIB cell line. Quinicrine fluores-
cence banding revealed that all cells were XO with a
reciprocal translocation, t(1;7)(p34;q34). The breakpoint on
chromosome 7 has been identified as a fragile site involved in
chromosomal translocations in cultured human T lympho-
cytes (53) and is close to the gene which encodes the beta
subunit of the T-cell receptor (22). Translocations at the
region p34-p36 of chromosome 1 occur in 5% of acute
nonlymphocytic leukemias and in 10% of non-Hodgkin
lymphomas (28).
Gene rearrangement at the T-beta locus. Karyotypic anal-
ysis of MIB cells disclosed a reciprocal translocation involv-
ing chromosomes 1 and 7. Because of the proximity of the
chromosomal breakpoint to the coding region of the beta
chain of the T-cell receptor (22), we determined the arrange-
ment of the T-beta sequences in MIB. The DNA arrange-
ment of this gene was analyzed by using the cDNA clone
Jurkat-2, which is specific for the beta chain of the T-cell
receptor. Hybridization with the Jurkat-2 clone to EcoRI-
digested MIB DNA was compared with hybridizations to H9
(a T-cell leukemia), CH5 (a biopsy of nasopharyngeal carci-
noma), Raji, and Bjab cells. Based on published hybridiza-
tions of the Jurkat-2 clone to leukemic human T-cell CEM
DNA (52), we can identify the fragments containing the two
constant-region genes and the variable-region genes of the
T-beta receptor. The constant-region sequences were pre-
sent in 12.0- and 4.0-kb fragments in EcoRI-digested DNAs
from CH5, Raji, and Bjab cells (Fig. 3B, lanes 3 to 5,
respectively). Variable-region T-beta sequences migrated as
9.0-, 6.0-, 3.6-, and 2.4-kb fragments. H9 DNA (lane 2)
contained the C,B2 4.0-kb fragment and a 9.0-kb rearranged
Cr31 fragment. The other C,B1 allele appeared to be deleted in
H9. MIB DNA (lanel) showed strong hybridization to three
fragments of 27.0, 16.0, and 4.0 kb. The larger bands were
rearrangements of the C,B1 loci of both alleles; the smallest
band represented Cr32. Variable sequences could be seen at
6.0 and 2.4 kb. The 9.0- and 3.6-kb fragments containing
variable-region sequences were not present in MIB DNA. In
summary, the MIB cell line is rearranged at both Cr31 loci of
the T-beta receptor and is deleted for DNA fragments of 9.0
and 3.6 kb which contain variable-region sequences. These
rearrangements and deletions may be the result of gene
rearrangement at the T-beta locus or may reflect the close
proximity of the chromosomal breakpoint.
Expression of the c-fgr locus in MIB cells. It is likely that
the chromosomal translocation was a contributing factor in
this transformation event. The breakpoint involved in this
translocation occurs in hematological neoplasia (2, 28).
Known cellular proto-oncogenes which have been mapped
to chromosome 1 include N-ras at 1p13 (8), B-lym at lp32
(33), lck at 1p32-35 (31), and c-fgr at lp34-36 (28, 36, 46). The
close proximity of c-fgr to the MIB translocation is of
particular interest in that a recent report indicates that
expression of the fgr oncogene is induced by EBV infection
(5). To determine whether c-fgr was expressed in MIB cells,
poly(A)+ RNA from the MIB cell line and the EBV-infected
Raji cell line was hybridized to a 32P-labeled SP6 RNA probe
synthesized from an 841-base-pair AvaI-BamHI fragment
representing only v-fgr oncogene sequences (Fig. 4). The
MIB line expressed a 2.3-kb message homologous to v-fgr in
contrast to the abundant 2.8-kb message detected in Raji
cells. The mRNA homologous to v-fgr was not present at an
elevated level. The altered size of the mRNA homologous to
v-fgr in MIB may reflect the close proximity of the chromo-
somal translocation or perhaps expression of a related cel-
lular locus. A recent report (31) describes a cellular gene,
Ick, which is less than 70% homologous to c-fgr, maps at
lp32-36 adjacent to the fgr locus on chromosome 1, and
encodes a 2.3-kb mRNA.
DISCUSSION
In this work, neonatal cord lymphocytes immortalized
after microinjection of EBV DNA did not retain the intact
viral genome. The majority of viral sequences were lost from
this line, and the EBV sequences were not expressed. This is
in marked contrast to cell lines established by infection with
EBV which retain multiple episomal copies of the intact viral
genome and express several mRNAs (48). The result that we
achieved is clearly different from the normal interaction of
the virus with a recipient host cell.
It is possible that regulated expression of several gene
functions is required for transformation by EBV. Fragmen-
tation of the genome, likely to occur in delivery of DNA by
microinjection, would interfere with this ordered process.
The presence and eventual loss of viral sequences in MIB
suggests that alterations in the recipient cells, ending in their
1 2
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FIG. 4. Total RNAs were prepared from Raji and MIB cells by
centrifugation of cell lysates through a cesium chloride step gradi-
ent. Poly(A)+ RNA was obtained by passage of total RNA through
oligo(dT) columns. Raji (lane 1) and MIB (lane 2) poly(A)+ RNAs (5
pug each) were electrophoresed in a formaldehyde-agarose gel and
blotted onto nitrocellulose. A 0.841-kb AvaI-BamHI fragment of
v-fgr, ligated into pGEM1, was labeled with SP6 polymerase and
[32P]CTP and hybridized to the Northern blot at 44°C in 50%
formamide. The blot was washed at 65°C. A band of 2.8 kb
representing c-fgr mRNA is present in the Raji RNA; a 2.3-kb
mRNA is present in the MIB RNA fractions. The markers at the left
denote 5.2- and 2.0-kb rRNAs.
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transformation, may have involved only transient viral ex-
pression.
Variation from the usual pattern of viral expression occurs
in Burkitt's lymphoma (BL). Three nuclear antigens and a
cytotoxic T-cell target (LYDMA) present at the surfaces of
EBV-infected cells are known to be expressed in latent EBV
infection (12, 18, 19, 26, 47). However, the latent protein
LYDMA appears not to be expressed in all BL cell lines;
several EBV-positive BL lines are not susceptible to HLA-
matched LYDMA-specific killing (42). Another of the latent
viral functions, EBNA-2, is apparently essential for trans-
formation in that P3HR-1, a nontransforming subclone of the
transforming BL Jijoye strain, is deleted for the sequences
which encode EBNA-2 (25, 40, 41). Superinfection of the
Raji cell line with HR-1 virus generates transformation-
competent recombinants which have regained the EBNA2
sequences (44). Daudi cells, derived from a BL cell, are also
deleted for EBNA-2 sequences (23). This implies that the
viral sequences which may be necessary for initiation of
transformation are no longer required in BL cells. This
may be due to changes effected in the cells by viral expres-
sion.
The permanent changes which result from chromosomal
translocation of cellular sequences in MIB may be sufficient
for transformation in the absence of continued viral expres-
sion. Genesis of a nonlethal growth-inducing translocation
would presumably be a rare event probably not fundamental
to the relatively efficient mechanism of EBV transformation
but intrinsic to the multistep progression to malignancy. It is
striking that the MIB chromosomal translocation which
involves DNA sequences having the inherent potential to
rearrange, and which may alter a cellular oncogene, so
parallels the translocations involving the immunoglobulin
loci in BL cells. This malignancy is characterized by distinc-
tive chromosomal translocations, t(8;14), t(2;8), and t(8;22),
which involve rearrangement of the immunoglobulin heavy-
or light-chain loci (6, 7, 10, 11, 29, 45). These translocations
are apparently due to aberrant somatic recombination result-
ing in translocation of the c-myc oncogene. Translocation of
c-myc seems to result in deregulation of expression of that
gene (9). The deregulation must be a significant contribution
to the malignant course of cell growth.
Similarly, the translocation in the MIB cell line may have
resulted in deregulation of a cellular oncogene. A 2.3-kb
mRNA homologous to c-fgr is expressed in the MIB cell
line. The locus of this oncogene is in close proximity to the
chromosomal breakpoint in the microinjected line (46). This
site is also near the location of the Ick gene and is a region of
chromosomal anomalies in human lymphomas (28, 31). Both
fgr and Ick encode protein tyrosine kinases belonging to the
src family of proteins believed to play a role in neoplastic
transformation. It has been shown that a 3.0-kb message
homologous to c-fgr is found in EBV-transformed peripheral
blood cells and EBV-positive BL cell lines (5). Both trans-
forming and nontransforming EBV isolates induce c-fgr
expression; therefore, induction of that proto-oncogene is
not alone sufficient for transformation. Further study is
necessary to determine whether the transformation event
which occurred in MIB involved alteration of the c-fgr or Ick
locus or perhaps alteration of a related locus mapping to the
breakpoint region.
EBV expression, which initially produces polyclonal-cell
proliferation, may potentiate cellular rearrangement in mul-
tiple stages of progression in the malignant process. The
multiple DNA rearrangements and chromosomal transloca-
tion of the MIB cell line may reflect aberrant activation of
somatic DNA-rearranging mechanisms and indicate possible
viral involvement in this process.
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